Inês Barroso

Image: Wellcome Library, London

University of Exeter, Exeter, UK

Inês leads the study Group at the University of Exeter, which uses genetic and genomic approaches to understand the aetiology of common and rare forms of metabolic disease.

Email: ines.barroso@exeter.ac.uk

Michael Boehnke

Department of Biostatistics and Center for Statistical Genetics, School of Public Health, University of Michigan

Mike's research focuses on the development of statistical methods for human gene mapping and their application to understand the genetic basis for type 2 diabetes and related traits and bipolar disorder

Email: boehnke@umich.edu

Jose Florez

Center for Human Genetic Research and Diabetes Unit, Massachusetts General Hospital, Cambridge, Massachusetts; Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts; Department of Medicine, Harvard Medical School, Cambridge, Massachusetts

Dr. Florez is an Assistant Professor at Harvard Medical School, an Assistant in Endocrinology at the Massachusetts General Hospital and an Associate Member at the Broad Institute. He is a clinically trained endocrinologist and Ph.D.-trained molecular geneticist, who is interested in extending the results of diabetes genetics research into the clinical arena and understanding the role of an individual's genetic profile in response to therapy

Email: jcflorez@partners.org

Claudia Langenberg

MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge

Claudia and her team work on investigating how genetic and lifestyle factors act together in their influence on type 2 diabetes and related metabolic disorders

Email: Claudia.Langenberg@mrc-epid.cam.ac.uk

Mark McCarthy

Wellcome Centre for Human Genetics, University of Oxford; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford; NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford

Mark's group focuses on susceptibility gene identification in type 2 diabetes and related phenotypes using large-scale genetic and genomic approaches; translating gene identification into biological insights and clinical advances; Genomic epidemiology; and Statistical genetics and bioinformatics

Email: mark.mccarthy@drl.ox.ac.uk

James Meigs

Associate Professor of Medicine, Harvard Medical School; General Medicine Division, Massachusetts General Hospital

James B. Meigs MD, MPH is Associate Professor of Medicine at Harvard Medical School and Massachusetts General Hospital. His group studies causes and prevention of type 2 diabetes and cardiovascular disease, approached using biochemical and genetic epidemiology of insulin resistance, type 2 diabetes and CVD, and health services translational research to improve type 2 diabetes and CVD prevention and clinical care

Email: jmeigs@partners.org

Inga Prokopenko

Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford; Wellcome Centre for Human Genetics, University of Oxford

Inga's work is focused on the genetics of Type 2 Diabetes (T2D) and related quantitative glycaemic and other metabolic traits

Email: inga@well.ox.ac.uk

Robert Sladek

Departments of Medicine and Human Genetics, McGill University, Montreal; Genome Quebec Innovation Centre, Montreal

Robert's group are involved in Functional characterization of risk loci for type 2 diabetes; developing strategies to identify causative genetic polymorphisms that underlie disease risk loci and determine their effects on cell physiology and gene regulation; and identify genetic variants that predispose to type 2 diabetes

Email: robert.sladek@mcgill.ca

Rona Strawbridge

Institute of Health and Wellbeing, University of Glasgow, UK; Department of Medicine Solna, Karolinska Institutet, Sweden

Rona's research uses genetics to explore the connection between mental health and cardiovascular disease, with a focus on glucometabolic components

Email: Rona.Strawbridge@ki.se

Richard Watanabe

Departments of Preventive Medicine and Physiology & Biophysics, Keck School of Medicine of USC Los Angeles, California

Richard's primary interests lie in the pathophysiology and genetics of type 2 diabetes mellitus and obesity

Email: rwatanab@usc.edu